EHC · CIK 785161
What Encompass Health Corporation told the SEC could break it.
Encompass Health's business is built around Medicare, and so is its risk. About 82% of 2025 revenue came from Medicare (roughly 65% fee-for-service plus 16% Medicare Advantage), and one Medicare Administrative Contractor has jurisdiction over a significant share of its hospitals, so a restrictive coverage interpretation or rate change could trigger large payment denials. The regulatory machinery around inpatient rehab compounds that: CMS IRF-PPS rate updates, the 60% Rule (failing it could reclassify its facilities as acute-care hospitals), Medicare sequestration, and the Review Choice Demonstration expanding to Texas and California in 2026. Its patient flow is concentrated too — 92% of admissions come from acute-care hospital referrals, so integrated-care arrangements among those referral sources could choke its pipeline.
3 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- ~82% of revenue from Medicare (65% FFS + 16% Medicare Advantage); single-MAC jurisdictionhigh
Encompass Health's payer mix is concentrated in Medicare — ~65% fee-for-service Medicare and ~16% Medicare Advantage in 2025 — and one Medicare Administrative Contractor (MAC) has jurisdiction over a significant number of its hospitals, so restrictive/incorrect MAC coverage interpretations or Medicare-rate changes could cause large payment denials and materially hurt results.
“Because one MAC has jurisdiction over a significant number of our hospitals and our hospitals derive a substantial portion of their revenue from Medicare, the adoption of restrictive or otherwise incorrect interpretations of coverage rules by that MAC could result in a large number of payment denials and materially and adversely affect our financial position, results of operations, and cash flows.”
SEC filing →As of 2026
Regulatory & policy
- CMS IRF-PPS rate-setting, the 60% Rule, RCD demonstration (TX/CA expansion) and sequestrationhigh
Encompass Health's reimbursement/regulatory risk is concentrated in Medicare inpatient-rehab rules — annual CMS IRF-PPS rate updates, the 60% Rule (failure could reclassify IRFs as acute-care hospitals), the expanding Review Choice Demonstration (RCD to Texas/California in 2026, covering 33 hospitals / ~11.9% of IRF Medicare claims), and the 2% Medicare sequestration.
“In December 2025, CMS announced the expansion of RCD to Texas and California, effective March 2, 2026 and May 1, 2026, respectively. With the expansion to those two states, we expect 33 of our current inpatient rehabilitation hospitals (representing approximately 11.9% of our IRF Medicare claims) to be subject to RCD.”
SEC filing →As of 2026
Other disclosures
- dependence on acute-care hospital referral sources (92% of admissions)medium
92% of Encompass Health's patients are admitted from acute-care hospitals following physician referrals, so its growth and profitability depend on maintaining close referral-source relationships; integrated-care JVs/networks between referral sources (e.g., acute-care hospitals) and other post-acute providers could hinder referrals to its rehab hospitals.
“The establishment of joint ventures or networks between referral sources, such as acute-care hospitals, and other post-acute providers may hinder patient referrals to us. The growing emphasis on integrated care delivery across the healthcare continuum increases that risk.”
SEC filing →As of 2026
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch